Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07292922

Digital-supported Orofacial Myofunctional Therapy in Subjects With Obstructive Sleep Apnoea: A Pilot Randomised Control Trial

Led by Hong Kong Metropolitan University · Updated on 2026-03-13

60

Participants Needed

1

Research Sites

12 weeks

Total Duration

On this page

Sponsors

H

Hong Kong Metropolitan University

Lead Sponsor

Q

Queen Mary Hospital, Hong Kong

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating Digital-supported Orofacial Myofunctional Therapy (d-MFT) for adults with mild to moderate obstructive sleep apnea (OSA). This pilot randomized controlled trial aims to assess the feasibility, acceptability, and early effectiveness of d-MFT, which combines facial recognition technology with proven orofacial exercises to strengthen throat muscles, improve airway function, and reduce OSA severity and symptoms. The study also explores participant satisfaction and barriers to using the therapy. Participants are randomly assigned to either a d-MFT intervention group or a waitlist control group. The intervention includes five 30-minute d-MFT sessions, two follow-up phone calls, and daily home exercises guided by a mobile app that offers real-time feedback and tracks adherence over three months. The control group receives no intervention during this period but continues usual care. After three months, outcome assessments are conducted for both groups. During the study, participants undergo polysomnography and complete questionnaires measuring sleepiness, sleep quality, and daily function at the start and end of the three months. Researchers also measure tongue pressure to assess muscle function. Adherence is monitored electronically through the app. Feasibility and acceptability are further evaluated via interviews to understand participants’ experiences and satisfaction. The total study duration for participants is three months, with data collected at baseline and after completing the intervention.

CONDITIONS

Brief Title

Digital-supported Orofacial Myofunctional Therapy in OSA

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years and above
  • Diagnosed with mild to moderate obstructive sleep apnoea (Apnoea-Hypopnea Index of 5-30 events per hour)
  • Indications for Continuous Positive Airway Pressure or oral appliance treatment but unable to tolerate or declined these treatments
  • Body Mass Index less than 30 kg/m2
Not Eligible

You will not qualify if you...

  • Presence of obstructive nasal disease or significant nasal obstruction
  • Unstable mental health issues
  • History of stroke
  • Unstable chronic respiratory, cardiac, or neurological conditions
  • Inability to provide informed consent
  • Prior oral, pharyngeal, or maxillofacial surgical therapy for sleep apnoea

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 3 months

Participants in the intervention group complete a 3-month digital-supported orofacial myofunctional therapy program consisting of five 30-minute sessions, two follow-up phone calls, and daily home exercises using a dedicated mobile app with real-time feedback.

5 sessions and 2 phone calls over 3 months

Outpatient Treatment

Duration - 3 months

Participants in the control group continue their usual care during this 3-month period without receiving the intervention.

No intervention visits

Follow-up Assessment

Duration - 1 day

After 3 months, participants undergo outcome assessments including sleep studies, questionnaires, and muscle function tests to evaluate therapy effects and adherence.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Queen Mary Hopsital

Hong Kong, Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

A

Agnes YK Lai, PhD

G

George OC Cheung, MSc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Modified Baveno Classification of Obstructive Sleep Apnoea...

Obstructive Sleep Apnea (OSA)

Actively Recruiting

18 locations

Assessment of Circuit Rebreathing During Continuous Positive...

Obstructive Sleep Apnea (OSA)

Actively Recruiting

1 location

Impact of Phenotypic and Psychological Characteristics and a...

Obstructive Sleep Apnea (OSA)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here